ZAP70 and diffuse large B-cell lymphoma: This study showed that, in comparison with the control group, DLBCL patients had lower mRNA expression of ZAP70, PI3K, and NFAT, while DLBCL medium/high‐risk group demonstrated a stronger reduction in expression than the DLBCL low‐risk patients.